Exosomes derived from HCC cells can induce sorafenib resistance in vitro by activating HGF/MET/AKT signaling pathway and inhibiting in vitro and in vivo sorafenib-induced apoptosis [150]. Here, AKT1 is linked to hepatocellular carcinoma.